GENENTECH INC (DNA) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 1015 transactions totaling $201.9M, demonstrating a bearish sentiment with -$198.4M in net insider flow. The most recent transaction on Dec 15, 2025 involved a sale of 736 shares valued at $6.5K.
No significant insider buying has been recorded for DNA in the recent period.
No significant insider selling has been recorded for DNA in the recent period.
Based on recent SEC filings, insider sentiment for DNA is bearish with an Insider Alignment Score of 1/100 and a net flow of -$198.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GENENTECH INC (DNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading DNA stock, having executed 1015 transactions in the past 90 days. The most active insider is Reshma P. Shetty (Executive), who has made 258 transactions totaling $59.8M.
Get notified when executives and directors at DNA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | P. Coen Steven | Executive | Sale | 736 | $8.89 | $6.5K | |
| Dec 12, 2025 | P. Coen Steven | Executive | Option Exercise | 1,174 | $N/A | $0 | |
| Dec 12, 2025 | P. Coen Steven | Executive | Option Exercise | 312 | $N/A | $0 | |
| Oct 17, 2025 | P. Coen Steven | Executive | Sale | 1,312 | $13.65 | $17.9K | |
| Oct 16, 2025 | P. Coen Steven | Executive | Option Exercise | 1,061 | $N/A | $0 | |
| Oct 16, 2025 | P. Coen Steven | Executive | Option Exercise | 312 | $N/A | $0 | |
| Oct 16, 2025 | P. Coen Steven | Executive | Option Exercise | 1,174 | $N/A | $0 | |
| Oct 1, 2025 | P. Coen Steven | Executive | Sale | 5,609 | $15.00 | $84.1K | |
| Sep 9, 2025 | O. Henry Christian | Executive | Sale | 10,000 | $11.06 | $110.6K | |
| Sep 8, 2025 | O. Henry Christian | Executive | Sale | 10,000 | $10.92 | $109.2K | |
| Aug 22, 2025 | P. Coen Steven | Executive | Sale | 310 | $12.40 | $3.8K | |
| Aug 21, 2025 | P. Coen Steven | Executive | Option Exercise | 156 | $N/A | $0 | |
| Aug 21, 2025 | P. Coen Steven | Executive | Option Exercise | 587 | $N/A | $0 | |
| Jul 16, 2025 | P. Coen Steven | Executive | Option Exercise | 1,174 | $N/A | $0 | |
| Jul 16, 2025 | P. Coen Steven | Executive | Option Exercise | 1,061 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 786 | $200.1M | 94.5% |
Disposition(D) | 15 | $6.1M | 2.9% |
Exercise(M) | 177 | $3.8M | 1.8% |
Purchase(P) | 4 | $1.7M | 0.8% |
Gift(G) | 11 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Award(A) | 14 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at GENENTECH INC has increased, with 26 insiders executing 1015 transactions across all time. Total sales of $200.1M significantly outpace purchases of $1.7M, resulting in a net outflow of $198.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.